naltrexone and Carcinoma, Epidermoid

naltrexone has been researched along with Carcinoma, Epidermoid in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, M; Montana, S; Patel, P; Sharma, P; Singh, R; Thakker, M	1
McLaughlin, PJ; Zagon, IS	1
Levin, RJ; McLaughlin, PJ; Ohlsson-Wilhelm, BM; Roesener, CD; Verderame, MF; Zagon, IS	1

Reviews

1 review(s) available for naltrexone and Carcinoma, Epidermoid

Article	Year
Naloxone and Maintenance Naltrexone as Novel and Effective Therapies for Immunotherapy-Induced Pruritus: A Case Report and Brief Literature Review. Journal of oncology practice, 2019, Volume: 15, Issue:6 Topics: Aged; Antibodies, Monoclonal, Humanized; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Immunotherapy; Naloxone; Naltrexone; Narcotic Antagonists; Prognosis; Pruritus; Rectal Neoplasms	2019

Article

Year

Naloxone and Maintenance Naltrexone as Novel and Effective Therapies for Immunotherapy-Induced Pruritus: A Case Report and Brief Literature Review.

Journal of oncology practice, 2019, Volume: 15, Issue:6

Topics: Aged; Antibodies, Monoclonal, Humanized; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Immunotherapy; Naloxone; Naltrexone; Narcotic Antagonists; Prognosis; Pruritus; Rectal Neoplasms

2019

Other Studies

2 other study(ies) available for naltrexone and Carcinoma, Epidermoid

Article	Year
Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells. International journal of oncology, 2004, Volume: 24, Issue:6 Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Adhesion; Cell Division; Colonic Neoplasms; Colony-Forming Units Assay; Enkephalin, Methionine; Head and Neck Neoplasms; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Pancreatic Neoplasms; Receptors, Opioid; Transplantation, Heterologous; Tumor Cells, Cultured	2004
Opioid growth factor regulates the cell cycle of human neoplasias. International journal of oncology, 2000, Volume: 17, Issue:5 Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Colonic Neoplasms; DNA Replication; Enkephalin, Methionine; Head and Neck Neoplasms; Humans; Naltrexone; Narcotic Antagonists; Neoplasm Proteins; Neoplasms; Pancreatic Neoplasms; Receptors, Opioid; Resting Phase, Cell Cycle; Tumor Cells, Cultured; Tumor Stem Cell Assay	2000

Article

Year

Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.

International journal of oncology, 2004, Volume: 24, Issue:6

Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Adhesion; Cell Division; Colonic Neoplasms; Colony-Forming Units Assay; Enkephalin, Methionine; Head and Neck Neoplasms; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Pancreatic Neoplasms; Receptors, Opioid; Transplantation, Heterologous; Tumor Cells, Cultured

2004

Opioid growth factor regulates the cell cycle of human neoplasias.

International journal of oncology, 2000, Volume: 17, Issue:5

Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Colonic Neoplasms; DNA Replication; Enkephalin, Methionine; Head and Neck Neoplasms; Humans; Naltrexone; Narcotic Antagonists; Neoplasm Proteins; Neoplasms; Pancreatic Neoplasms; Receptors, Opioid; Resting Phase, Cell Cycle; Tumor Cells, Cultured; Tumor Stem Cell Assay

2000